Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nebbioso

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Molecular Cancer|June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathwayNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Journal of Medicinal Chemistry|November 30, 2012
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cellsDante Rotili, Domenico Tarantino, Angela Nebbioso, et al.
Journal of Personalized Medicine|November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and ShadowsMarco Montella, Giovanni Ciani, Vincenza Granata, et al.
European Journal of Medicinal Chemistry|August 10, 2018
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studiesMargherita Brindisi, Johanna Senger, Caterina Cavella, et al.
Journal of Medicinal Chemistry|December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer CellsSergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Clinical Epigenetics|September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Cancer Research|February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Cell Death & Disease|October 6, 2025
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexiaAda Pesapane, Lucia Capasso, Maria Rosaria Del Sorbo, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Molecular Cancer|June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathwayNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Journal of Medicinal Chemistry|November 30, 2012
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cellsDante Rotili, Domenico Tarantino, Angela Nebbioso, et al.
Journal of Personalized Medicine|November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and ShadowsMarco Montella, Giovanni Ciani, Vincenza Granata, et al.
European Journal of Medicinal Chemistry|August 10, 2018
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studiesMargherita Brindisi, Johanna Senger, Caterina Cavella, et al.
Journal of Medicinal Chemistry|December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer CellsSergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Clinical Epigenetics|September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Cancer Research|February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Cell Death & Disease|October 6, 2025
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexiaAda Pesapane, Lucia Capasso, Maria Rosaria Del Sorbo, et al.
Pageof 15